This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Recent Videos Related Content FDA to Evaluate Merck’s Doravirine, Islatravir Regimen for HIV-1 Killian Meara July 10th 2025 Article The FDA set a Prescription Drug User Fee Act (PDUFA) date of April 28, 2026. Subscribe Now!
1 "Lilly was the first company to offer a self-pay solution for an FDA-approved obesity medication, and we continue to work to expand coverage for Zepbound. As part of the program, all dosages of semaglutide will be delivered directly to the patient’s home and filled by CenterWell Pharmacy. With the new addition, 12.5
link] Recent Videos Related Content FDA Grants Expanded Interchangeability Designation to Yuflyma Ashley Gallagher May 23rd 2025 Article Adalimumab-aaty (Yuflyma) prefilled syringes and autoinjectors are now fully interchangeable with the reference product adalimumab (Humira) across marketed dosage forms and strengths.
SHOW MORE The FDA approved acalabrutinib as a frontline option for untreated mantle cell lymphoma. Mann School of Pharmacy and Pharmaceutical Sciences. For this application, the FDA collaborated with the Australian Therapeutic Goods Administration, Health Canada, and Switzerland’s Swissmedic. January 16, 2025.
Selection of an appropriate OTC analgesic should take into consideration various patient factors, including the patient’s overall health status, current medical conditions, and medication profile, as well as patient preferences, which are often influenced by dosage form, required dosing intervals, and cost of OTC medication.
It will be interesting to see what dosage form these data prompt the future development of. It also introduces a question on how to optimize the PK/pharmacodynamic profile for protein degraders, such as cereblon E3 ligase modulatory drugs and proteolysis-targeting chimeras, which are a burgeoning area of therapeutic development.”
2 There are several FDA-approved adalimumab biosimilars—including interchangeable products—that are available to patients. 1 Specialtypharmacy dispensing data identified 67 patients with a diverse range of inflammatory conditions for study screening, and of this group, only 32 had eligibility criteria for enrollment.
The Orange Book is the reference, and it allows the FDA to declare something [to be] therapeutically equivalent. The FDA Approval Process Within the FDA approval process, the 505(b)(1) new drug application (NDA) submission pathway is the pathway by which new drugs are able to seek approval.
A recent supplemental new drug application (sNDA) submitted to the FDA seeks to expand lumapeterone’s approval based on compelling relapse prevention data. A recent supplemental new drug application (sNDA) submitted to the FDA seeks to expand lumapeterone’s approval based on compelling relapse prevention data.
A group of experts will present an encore abstract titled " Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using Real-World Data " at the 2025 Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20.
Image credit: Shutter2U | stock.adobe.com Biosimilars are biologic products highly similar to an FDA-approved reference product, with no clinically meaningful differences in safety, purity, or potency. Misconceptions can lead to unnecessary hesitation, increased health care spending, and reduced access to important biologic treatments.
FDA approval of LIMITX for broader use could significantly impact opioid misuse prevention and save lives. Or, as FDA officials like to call it, “multiple tablet ingestion”—I guess it sounds better to them. LIMITX technology, developed by Abuse Deterrent Pharma and Acura Pharmaceuticals, controls drug release to reduce overdose risk.
Meloxicam injection (Xifyrm; Azurity Pharmaceuticals, Inc) received FDA approval for use in adults for the management of moderate-to-severe pain, either alone or in combination with non-steroidal anti-inflammatory drug (NSAID) analgesics. Designing the ideal perioperative pain management plan starts with multimodal analgesia. August 24, 2018.
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
2-4 In the United States, the FDA had approved 44 cell therapy products as of March 6, 2025. In October 2024, CAR T therapy axicabtagene ciloleucel (Yescarta; Kite Pharma) received FDA regenerative medicine advanced therapy designation as a first-line treatment for high-risk large B-cell lymphoma. Accessed February 2025. March 6, 2025.
This international study is ongoing despite the recent FDA decision to reject MDMA-assisted therapy for PTSD, and it has the potential to add another treatment paradigm for patients with cancer. Potential Roles of the Oncology Pharmacist My friend died of his metastatic cancer in early 2025.
Limitations included open-label design and dosage constraints, but the multicountry approach enhanced generalizability and external validity. All patients underwent a 20-week correction period for dosage titration and Hb correction, which was followed by an 8-week evaluation for efficacy assessments. 1 REFERENCES 1.
In addition, the dosage [of 2000 IU per day] used in the research is far below the target dose for correcting vitamin D deficiency, which is usually 50,000 IU per week,” Carvalho-Pessoa said in a news release. 1,2 “Even with a small sample of participants, it was possible to observe a significant difference in the response to chemotherapy.
Animal studies reveal dose-dependent hepatic responses to CBD, supporting the need for cautious monitoring even at consumer-relevant dosages. 2 Despite its widespread acceptance, an FDA-led clinical trial unexpectedly found that even a low-dose CBD regimen led to clinically meaningful liver enzyme elevations in 5.6%
The biosimilar demonstrated comparable efficacy and safety to Stelara in a phase 3 clinical trial, supporting its FDA approval. Steqeyma provides a new dosage form and strength, enhancing treatment flexibility for young patients with chronic inflammatory conditions. In December 2024, the FDA approved the biosimilar in 45-mg/0.5
Zepbound (tirzepatide) is a once-weekly injectable GIP/glucagon-like peptide-1 (GLP-1) receptor agonist that’s been approved by the Food and Drug Administration (FDA) to promote weight loss in adults with obesity or who are overweight with a weight-related health condition. You may need more or less than that based on your prescribed dosage.
2,3 LIMBER is a phase 1, open-label, dose escalation study evaluating INCB057643 as a monotherapy at a dose escalation of 4 to 12 mg daily (part 1) or in combination with ruxolitinib at a dosage of 4 mg once daily and escalating to the maximum tolerated dose in part 1 (part 2).
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
Both agents received FDA approval for the treatment of patients with RRMM who have received at least 4 prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 antibody. The investigators assessed a total of 90 patients who received talquetamab at a dosage of 0.8 mg/kg every 2 weeks.
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
The price of Nucala can vary depending on the pharmacy and the specific dosage form, such as an autoinjector or prefilled syringe. Because Nucala is a biologic drug approved by the Food and Drug Administration (FDA), any potential biosimilar must also undergo strict FDA approval. Is Nucala covered by insurance?
Cosentyx (secukinumab) is a brand-name injectable biologic drug that is approved by the Food and Drug Administration (FDA) to treat moderate to severe plaque psoriasis , active psoriatic arthritis , and spinal arthritis (active ankylosing spondylitis, non-radiographic axial spondyloarthritis, and enthesitis). How much does Cosentyx cost?
Dupixent was approved by the Food and Drug Administration (FDA) to treat atopic dermatitis (eczema), asthma, prurigo nodularis, eosinophilic esophagitis (EoE) , chronic sinusitis with nasal polyps, and chronic obstructive pulmonary disease (COPD). This is called step therapy. The price varies though, and most people don’t pay that price.
As a specialty medication , Humira requires specific handling, administration, and monitoring, so you have to get it from a specialtypharmacy or other designated location. Fortunately, the Food and Drug Administration (FDA) has approved several Humira biosimilars , including Amjevita, Cyltezo, Hadlima, and Yuflyma.
If your health insurance company or Medicare plan covers Rinvoq, it may require the prescription to be filled by a specialtypharmacy , which fills medications that require special dosage, handling, administration, storage, or shipping requirements. If you have Medicare prescription coverage, your coverage also varies by plan.
Food and Drug Administration (FDA) to treat obesity in the short term and is meant to be combined with exercise, calorie reduction, and behavioral modifications. This is largely a historical remnant because phentermine was originally FDA-approved in the 1950s for short-term use,” Dr. Garcia-Webb explains. It’s approved by the U.S.
BCPS, Lead Clinical Pharmacy Specialist at KSP SpecialtyPharmacy. If your prednisone dosage is once daily, consider taking the pills in the morning to reduce its likelihood of affecting your sleep. If your dosage is twice daily, take the second dose for the day no later than mid-afternoon. Take it in the morning.
The Food and Drug Administration (FDA) has approved Fasenra for maintenance treatment of severe asthma. Nucala has a more robust array of indications and has been FDA approved to treat severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis (EGPA), hypereosinophilic conditions, and rhinosinusitis with nasal polyps.
Before issuing coverage, the insurance provider typically wants to confirm that Remicade is medically necessary for you and that you’re using it to treat a condition the Food and Drug Administration (FDA) has approved it to treat.
It is approved by the Food and Drug Administration (FDA) to treat plaque psoriasis , psoriatic arthritis , Crohn’s disease , and ulcerative colitis. According to the FDA , biological products are complex medicines made from living cells, like those from plants or animals. Wezlana (ustekinumab-auub) was FDA approved on Oct.
The subcutaneous dosage of Stelara for psoriasis is as follows: For adults with psoriasis who weigh 220 pounds or less: The first dose is 45 mg. The dosage for pediatric patients (6 to 17 years of age) is based on weight. This price does not include additional pharmacy charges, so the total depends on the pharmacy.
Remicade: Key differences Remicade, made by the pharmaceutical company Janssen Biotech, was approved by the Food and Drug Administration (FDA) in 1998. According to the FDA , most biologics are complex mixtures that cannot be easily characterized or identified. It is classified as both a biologic drug and a monoclonal antibody.
ml What is the standard dosage? Adults Pediatric patients for certain indications Adults Pediatric patients for certain indications Cyltezo vs. Humira: Conditions treated Cyltezo and Humira are both approved by the Food and Drug Administration (FDA) for the same uses, although the ages for use vary for some indications. ml, 20 mg/0.4
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content